Skip to content
Home/Companies/Biotech/Dilepix
DI

Dilepix

Biotech·France·Active·6yr hold

Dilepix is a biotechnology company, headquartered in France.

Entry
2020
Hold
6yr
Status
Active
Est. EV
–

Who owns Dilepix?

Dilepix is currently owned by Elaia Partners through Elaia Alpha II (2020 vintage), since 2020.

Hand-verified · updated 2026-04-21

Elaia Partners
Investor
Elaia Partners
Elaia Alpha II · 2020 · VC

Key facts

HQFrance
SectorBiotechnology

More from Elaia Alpha II

Other portfolio companies in the same fund.

Alice & Bob
Active
Data & AnalyticsFrance· 2022
Arsen
Active
CybersecurityFrance· 2022
Aviwell
Active
BiotechUS· 2022
Corporatings
Active
SoftwareFrance· 2022
Giskard
Active
Data & AnalyticsFrance· 2022
Kheops
Active
Data & AnalyticsFrance· 2022

More PE-backed in Biotech

Comparable biotech deals from other GPs.

GenSight Biologics
Active
Sofinnova PartnersFrance
InBrain Pharma
Active
Finovam GestionFrance
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
Univercells
Exited 2023
AdBio PartnersBelgium
to
Data refreshed weekly · Sourced from public filings